Article info
PDFReview
Systemic biomarkers of exposure associated with ENDS use: a scoping review
- Correspondence to Dr Marzena Hiler, Center for Tobacco Products, Office of Science, US Food and Drug Administration, Silver Spring, Maryland, USA; Marzena.Hiler{at}fda.hhs.gov
Citation
Systemic biomarkers of exposure associated with ENDS use: a scoping review
Publication history
- Received July 2, 2021
- Accepted October 13, 2021
- First published November 3, 2021.
Online issue publication
June 20, 2023
Article Versions
- Previous version (20 June 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.